Volume 1, Issue 4
September 2006
In This Issue  

Quick Links  

Upcoming Event Information  

Join our list  
Join our mailing list!

Dear Valued Client,

Metametrix has kicked off September with new programs and tests to ring in the fall season! We began with a new teleconferencing series on the 7th, featuring "Mitochondrial Function and Disease". In addition to the teleconference series, the launch of our Celiac Profile offers new testing options for food antibodies and allergies. Read on for details!

Celiac Disease
 
Testing for IgA antibodies and Celiac Disease
Celiac

Celiac Disease is an immune mediated response to gluten that affects the gastrointestinal tract. Inherited factors make some individuals sensitive to a protein called gliadin, which is a part of the total protein or gluten found in grains. When undigested gluten reaches the small intestine, gliadin peptides activate auto-immune reactions in susceptible individuals.

Available the week of September 25th!

Metametrix Celiac Profile


Teleconference Series
 
Join us October 5: Evaluating B Vitamin Status in Autism
phone

The first teleconference, "Evaluating Mitochondrial Function in Disease: Managing the Fatigued Patient," on September 7th was an overwhelming success! After reviewing the responses we have switched the teleconference line to a toll free number allowing an unlimited number of participants. Join us October 5th by calling 800-704-9804 and entering participation code 65754613# when prompted. Additionally, before or after the teleconference, any questions can be submitted to teleconferences@metametrix.com.

Click below to hear the audio recording or access the case studies for "Evaluating Mitochondrial Function in Disease: Managing the Fatigued Patient"

Audio Recording

Case Studies


Breast Cancer Awareness
 
Get your Estronex Patient Brochures
estronex

Metametrix would like to help support Breast Cancer Awareness month in October. Please contact client services at 800-221-4640 or online to receive your Estronex patient brochures.

The Estronex test is a measurement of two important forms of estrogen: 2-OHE1 (the "good" estrogen) and 16-α-OHE1 (the "bad" estrogen). Studies have shown that women with low Estronex 2/16 ratios have much higher rates of breast cancer.



We hope you are enjoying the new Metametrix Memo E-Newsletter. Next month is Breast Cancer Awareness month. Metametrix will spotlight the Estronex test, estrogen related cancers, and women's health. Also, watch for updates to the IgG antibodies profile! If you have any questions or comments on Metametrix please contact us!

Sincerely,

logo2
Metametrix Clinical Laboratory

Phone: 1-800-221-4640
Fax: 1-770-441-2237